The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; 3 of the 7 sources its claims cite were checked for support.
Surveillance to track progress toward polio eradication—worldwide, 2020–2021.
Open accessAbstract
Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%.By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan).However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020-2021 (1,2).cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis.The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance).The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January-September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3).This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4).In 2021, a total of 32 (74%) priority countries † met * Countries selected for this 2020-2021 report were identified as priority countries in the WHO Global Polio Surveillance Action Plan (GPSAP), 2022-2024 because of persistent surveillance gaps and susceptibility to poliovirus transmission or had ≥1 WPV1 or cVDPV isolates detected from AFP or environmental surveillance in 2021
Overview
CoChat Summary
TL;DR
This report summarizes 2020–2021 polio surveillance performance in 43 priority countries and finds that national AFP surveillance improved in 2021, especially in the African Region, but substantial national and subnational gaps remained. The paper also shows that environmental surveillance and GPLN testing continued to detect cVDPV and WPV circulation, including a WPV1 case in Malawi in 2021.
Key findings
- In 2021, 32/43 (74%) priority countries met both national AFP surveillance indicator targets, up from 23/43 (53%) in 2020.
- In the African Region, 50% of 28 priority countries met both national targets in 2020 and 79% did in 2021; at the first subnational administrative level, 52% met both targets in 2020 and 75% in 2021.
- In 2020–2021, environmental surveillance detected cVDPV2 before a confirmed AFP case in Afghanistan, Liberia, and Senegal, and detected it only through sewage in Djibouti, Egypt, Gambia, Iran, Mauritania, and Uganda.
- GPLN tested 147,582 stool specimens in 2020 and 170,881 in 2021; cVDPVs were isolated from 1,067 AFP cases in 2020 and 659 in 2021.
Methods
- The report reviewed surveillance indicators for 43 priority countries at risk for poliovirus transmission, using two AFP performance measures: nonpolio AFP rate ≥2 per 100,000 children aged <15 years and stool adequacy ≥80%.
- It summarized AFP surveillance, environmental surveillance, and GPLN laboratory data for 2020 and 2021, with regional and subnational comparisons.
- Main analyses were descriptive, reporting counts, percentages, and changes over time by WHO region and country.
Limitations
- The paper states that security issues and hard-to-access populations could affect AFP surveillance and limit interpretation of surveillance indicators.
- It states that high NPAFP rates do not necessarily mean highly sensitive surveillance because some reported cases may not meet the case definition, some AFP cases may go undetected, and background NPAFP rates may vary.
- It states that stool adequacy depends on accurate paralysis onset dates from field investigations. Evidence in the text also suggests a limitation: the report is descriptive surveillance monitoring, so it does not estimate causal effects of COVID-19 or other factors beyond observed changes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
3 Valid · 1 Not valid · 5 Not checked · 47 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In Afghanistan, WPV1 was isolated from only one environmental surveillance sample in 2021 compared with 35 samples from 15 sites in 2020 (7).”
§ Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2020–2021 Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020–2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January–September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries† met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication. > Environmental Surveillance
What the sources say
- Partly supportedcites [7] Sadigh, 2022, Progress toward poliomyelitis eradication—Afghanistan, January 2020–November 2021., MMWR Morb Mortal Wkly Rep sourceExperimental — accuracy not yet measured
The Poliovirus Surveillance section (Environmental surveillance) states 'One WPV1 ES-positive sample was detected during January–November 2021, a 97% decrease compared with 34 detected during the same period in 2020,' and the Table (All regions) gives 22 (Jan–Jun 2020) + 13 (Jul–Dec 2020) = 35 WPV1-positive ES samples for full-year 2020 versus 1 (0.3%) for Jan–Nov 2021, so the one-in-2021 versus 35-in-2020 comparison is supported. However, no passage of our copy attributes those 2020 positives to '15 sites'; our copy only says ES is conducted at 25 sites in 13 provinces and lists the provinces (Kabul, Nangarhar, Kunduz, Khost, Helmand, Kandahar, plus Herat) where WPV1-positive ES samples were detected in 2020. The site count of 15 is therefore not supported by this source, and the 2021 figure is bounded to January–November (data as of January 11, 2022), which the citing sentence drops. (LLM, conf=0.72)
plainn = 35- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“All priority countries faced setbacks in surveillance performance in 2020 because of the COVID-19 pandemic and associated risk mitigation measures (3)”
§ Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2020–2021 Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020–2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January–September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries† met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication. > Discussion
What the sources say
- Partly supportedcites [3] Zomahoun, 2021, Impact of COVID-19 pandemic on global poliovirus surveillance., MMWR Morb Mortal Wkly Rep sourceExperimental — accuracy not yet measured
The Discussion reports that global polio surveillance declined in 2020 and suggests the pandemic and mitigation measures contributed. It does not establish setbacks in every priority country: the Acute Flaccid Paralysis Surveillance section reports increased case reporting in 29 countries and no change in eight. The Discussion also says country-specific assessments are needed before attributing declines to the pandemic and identifies some declines with other causes. Page numbers were not available in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Because paralysis occurs in <1% of poliovirus infections, environmental surveillance can detect poliovirus circulation even in the absence of confirmed paralytic polio cases (6).”
§ Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2020–2021 Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020–2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January–September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries† met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication. > Environmental Surveillance
What the sources say
- Partly supportedcites [6] Asghar, 2014, Environmental surveillance for polioviruses in the Global Polio Eradication Initiative., J Infect Dis sourceExperimental — accuracy not yet measured
The RATIONALE FOR ES section says infected people excrete poliovirus whether or not they have symptoms. The WPV Transmission in Egypt and Israel section reports virus detected in sewage despite no confirmed acute flaccid paralysis cases. Our copy does not give the claimed figure that paralysis occurs in less than 1% of infections. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“cVDPV1 cases declined from 31 in 2020 to three in 2021 (all from Yemen)”
§ Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2020–2021 Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020–2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January–September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries† met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication. > Acute Flaccid Paralysis Surveillance
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In 2020, a total of 140 WPV1 cases were detected in EMR countries (56 in Afghanistan and 84 in Pakistan)”
§ Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2020–2021 Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020–2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January–September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries† met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication. > Acute Flaccid Paralysis Surveillance
plainn = 140- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 56 claims and to verify the 4 references still open.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Whether or not AFP surveillance performance indicator targets are met, gaps often exist in poliovirus detection subnationally.”
From Progress Toward Polio Eradication-Worldwide, January 2020–April 2022 (2022) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Among the 43 priority countries, 32 (74%) met both surveillance indicator targets nationally in 2021.”
From Progress Toward Polio Eradication-Worldwide, January 2020–April 2022 (2022) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Subnational performance was highly variable (7).”
From Progress Toward Polio Eradication-Worldwide, January 2020–April 2022 (2022) · cites this paper as [7]
In the citing paper
“COVID-19 pandemic prevention efforts have affected AFP surveillance sensitivity and the administration of routine childhood immunizations globally (4,7–9).”
From Progress Toward Polio Eradication-Worldwide, January 2020–April 2022 (2022) · cites this paper as [7]
Citations
Cites
Global polio eradication initiative
Koenig‐Archibugi, M. (2011) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 523
Environmental surveillance for polioviruses in the Global Polio Eradication Initiative.
Asghar, H., Diop, O. M., Weldegebriel, G., Malik, F., Shetty, S., El Bassioni, L., Akande, A. O., Al Maamoun, E., Zaidi, S., Adeniji, A. J., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu384 · Cited by 427
Self-citationUpdate on Vaccine-Derived Polioviruses-Worldwide, January 2017–June 2018
Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Sutter, R. W., Wassilak, S. G. F., & Burns, C. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6742a5 · Cited by 197
Self-citationUpdate on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021
Alleman, M. M., Jorba, J. C., Henderson, E., Diop, O. M., Shaukat, S., Traore, M. A., Wiesen, E., Wassilak, S. G. F., & Burns, C. C. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7049a1 · Cited by 73
Self-citationProgress toward polio eradication—worldwide, January 2019–June 2021.
Bigouette, J. P., Wilkinson, A. L., Tallis, G., Burns, C. C., Wassilak, S. G. F., & Vertefeuille, J. F. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7034a1 · Cited by 62
Self-citationDiop, O. M., Kew, O. M., de Gourville, E. M., & Pallansch, M. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix092 · Cited by 43
Self-citationImpact of COVID-19 pandemic on global poliovirus surveillance.
Zomahoun, D. J., Burman, A. L., Snider, C. J., Chauvin, C., Gardner, T., Lickness, J. S., Ahmed, J. A., Diop, O., Gerber, S., & Anand, A. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm695152a4 · Cited by 39
Self-citationProgress Toward Poliomyelitis Eradication — Nigeria, January–December 2017
Bolu, O. O., Nnadi, C. D., Damisa, E., et al. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6708a5 · Cited by 34
Mbaeyi, C., Alleman, M. M., Ehrhardt, D. T., Wiesen, E., Burns, C. C., Liu, H., Ewetola, R., Seakamela, L., Mdodo, R., Ndoutabé, M., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809a2 · Cited by 32
World Health Organization Regional Assessments of the Risks of Poliovirus Outbreaks
Lowther, S. A., Roesel, S., O’Connor, P. M., Landaverde, M., Oblapenko, G., Deshevoi, S., Ajay, G., Buff, A. M., Safwat, H., Salla, M., et al. (2013) · Risk Analysis · doi:10.1111/risa.12032 · Cited by 31
Cited by
Progress Toward Polio Eradication-Worldwide, January 2020–April 2022
Rachlin, A., Patel, J. C., Burns, C. C., Jorba, J., Tallis, G., O’Leary, A., Wassilak, S. G. F., & Vertefeuille, J. F. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7119a2 · Cited by 61
Self-citationUpdate on Wild Poliovirus Type 1 Outbreak-Southeastern Africa, 2021–2022
Davlantes, E., Greene, S. A., Tobolowsky, F. A., Biya, O., Wiesen, E., Abebe, F., Weldetsadik, M. B., Eboh, V. A., Chisema, M. N., da Conceição Mário, B., et al. (2023) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7215a3 · Cited by 16
Self-citation
Metadata
- Authors
- Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., & Ahmed, J.
- Affiliations
- National Center for Immunization and Respiratory Diseases (US)
- Corresponding author
- Wilkinson, Amanda L.
- Venue
- MMWR Morbidity and Mortality Weekly Report
- Published
- 2022-04-15
- Volume
- 71
- Issue
- 15
- Pages
- 538-544
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC9020859
- OpenAlex
- W4225529761
- Cited by
- 30
- References
- 14
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 14 · 2022: 6
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- National Center for Immunization and Respiratory Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- polio eradication, acute flaccid paralysis surveillance, wild poliovirus type 1, circulating vaccine-derived poliovirus, environmental surveillance, poliovirus transmission, COVID-19 pandemic impact on vaccination
- MeSH terms
- COVID-19, Humans, Paralysis, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Global Health, Immunization Programs, Poliovirus, Pandemics, Disease Eradication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surveillance to track progress toward polio eradication—worldwide, 2020–2021. https://app.cochat.ai/papers/10.15585/mmwr.mm7115a2
- The paper
- Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., & Ahmed, J. (2022). Surveillance to track progress toward polio eradication—worldwide, 2020–2021. MMWR Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7115a2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.